Consistent with these observations, SPHK1 mRNA and protein levels have been found to be significantly elevated in various tumor types [22-26], which prompted us to ask whether the expression of SPHK1 is upregulated and clinically associated with the progression of SGC. Here, SPHK1 is linked to neoplasm.